Dr. Xin Sun is Professor of Clinical Epidemiology and Evidence-based Medicine Research Center at West China Hospital, Sichuan University in Chengdu, China. He serves as the directors of Chinese Evidence-based Medicine Center, NMPA Key Lab for Real-world Data Research and Evaluation in Hainan, Cochrane China Center, and MAGIC China Center, and works as Executive Editor-in-Chief of the Chinese Journal of Evidence-based Medicine and Journal of Evidence-based Medicine, and associate editor of Value in Health Regional Issue. Dr. Sun is an external expert of the Center for Drug Evaluation (CDE), Center for Medical Devices Evaluation (CMDE), and Center for Drug Re-evaluation (CDR) of National Medical Products Administration (NMPA), as well as an external expert of National Healthcare Security Administration.

Dr. Sun leads a group of researchers (CREAT Group) with a broad array of expertise in real-world data studies, clinical trials, evidence synthesis and recommendations, and healthcare economics and policy research. Dr. Sun’s research interests include clinical evaluation, post-approval monitoring and policy research of medical products; clinical research and evaluation of traditional Chinese medicine; health care research on pregnancy, critical care and stroke. In the past several years, Dr. Sun has received over 20 public research grants including those from Natural Science Foundation of China, Chinese Ministry of Science and Technologies, National Medical Products Administration, and China Medical Board. He has published over 130 peer-reviewed articles, including those published in NEJM, JAMA, and BMJ. He became the most productive BMJ author from China, and received the BMJ Award for excellence in research.

Dr. Sun also severs as President of ISPOR West China Chapter, Vice Chairs of Evidence-based Medicine Committee of the Chinese Medical Doctor Association, Rational Drug Use Committee of the Chinese Geriatric Research Association, and Evidence-based Pharmacy Committee of the Chinese Pharmacy Association.